Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus - Covid 19 Information Sharing Forum -- Ignore unavailable to you. Want to Upgrade?

To: maceng2 who wrote (2874)	8/19/2023 7:06:55 PM
From: Thomas M.	3 Recommendations Recommended By golfer72 maceng2 SirWalterRalegh Respond to of 5936

I'm reposting this old 2021 story because it's pretty remarkable: Pfizer abandoned a market of 1.4 billion people simply because the government requested small local safety trials and because Pfizer wasn't granted legal immunity. Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study. The Indian government has also declined to meet the U.S. companies' requests for legal protection over any side-effects from the use of their shots reuters.com reuters.com Tom